PL2364975T3 - Nowa pochodna amidu i jej zastosowanie jako lek - Google Patents
Nowa pochodna amidu i jej zastosowanie jako lekInfo
- Publication number
- PL2364975T3 PL2364975T3 PL09823571T PL09823571T PL2364975T3 PL 2364975 T3 PL2364975 T3 PL 2364975T3 PL 09823571 T PL09823571 T PL 09823571T PL 09823571 T PL09823571 T PL 09823571T PL 2364975 T3 PL2364975 T3 PL 2364975T3
- Authority
- PL
- Poland
- Prior art keywords
- medicine
- amide derivative
- novel amide
- novel
- derivative
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008276147 | 2008-10-27 | ||
| PCT/JP2009/068386 WO2010050461A1 (ja) | 2008-10-27 | 2009-10-27 | 新規アミド誘導体およびその医薬としての用途 |
| EP09823571.6A EP2364975B1 (en) | 2008-10-27 | 2009-10-27 | Novel amide derivative and use thereof as medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2364975T3 true PL2364975T3 (pl) | 2013-12-31 |
Family
ID=42128822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09823571T PL2364975T3 (pl) | 2008-10-27 | 2009-10-27 | Nowa pochodna amidu i jej zastosowanie jako lek |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8354401B2 (pl) |
| EP (1) | EP2364975B1 (pl) |
| JP (1) | JP5478499B2 (pl) |
| KR (1) | KR101712679B1 (pl) |
| CN (1) | CN102239152B (pl) |
| AU (1) | AU2009310952B2 (pl) |
| CA (1) | CA2741661C (pl) |
| DK (1) | DK2364975T3 (pl) |
| ES (1) | ES2427397T3 (pl) |
| MX (1) | MX2011004372A (pl) |
| PL (1) | PL2364975T3 (pl) |
| PT (1) | PT2364975E (pl) |
| RU (1) | RU2487124C2 (pl) |
| TW (1) | TWI471322B (pl) |
| WO (1) | WO2010050461A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9051296B2 (en) | 2009-11-16 | 2015-06-09 | Raqualia Pharma Inc. | Aryl carboxamide derivatives as TTX-S blockers |
| JP2011246461A (ja) * | 2010-04-27 | 2011-12-08 | Mitsubishi Tanabe Pharma Corp | 新規アミド誘導体を含有する医薬組成物 |
| TWI525090B (zh) * | 2010-04-27 | 2016-03-11 | Mitsubishi Tanabe Pharma Corp | Novel amide derivatives and their use as pharmaceuticals |
| JP5800786B2 (ja) * | 2011-10-26 | 2015-10-28 | 田辺三菱製薬株式会社 | 新規アミド誘導体を有効成分として含有する医薬組成物 |
| EP2822944A1 (en) | 2012-03-05 | 2015-01-14 | Amgen, Inc. | Oxazolidinone compounds and derivatives thereof |
| US9701689B2 (en) | 2012-11-30 | 2017-07-11 | Kyowa Hakko Kirin Co., Ltd. | Substituted pyridines and pyridazines as CCR10 receptor inhibitors |
| CN104262238B (zh) * | 2014-08-29 | 2016-08-03 | 西安交通大学 | 一种芳杂环联苯类Bcr-Abl抑制剂及其制备方法和应用 |
| RU2741576C2 (ru) | 2014-10-24 | 2021-01-27 | Лэндос Байофарма, Инк. | Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2 |
| MX376130B (es) * | 2015-07-09 | 2025-03-07 | Mitsubishi Tanabe Pharma Corp | Derivados novedosos de imida y su uso como medicamento. |
| JP6856555B2 (ja) * | 2017-01-06 | 2021-04-07 | 田辺三菱製薬株式会社 | 医薬組成物 |
| CN113316571B (zh) * | 2018-11-14 | 2024-12-31 | 阿林齐生物制药公司 | 用于治疗白细胞介素1β相关病症的吡啶磺酰胺化合物 |
| AU2020407645B2 (en) | 2019-12-20 | 2022-10-06 | Nimmune Biopharma, Inc. | Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same |
| US12234578B2 (en) | 2020-01-29 | 2025-02-25 | Wisconsin Alumni Research Foundation | Tannin composite fibers |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US6638952B1 (en) * | 1997-03-04 | 2003-10-28 | Pharmacia Corporation | Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| IL131493A (en) * | 1997-03-04 | 2004-05-12 | Monsanto Co | Aromatic compounds of the hydroxamic sulfonyl alpha-deroxamic acid and their use in the preparation of drugs for the treatment of a condition associated with pathological activity of the metalloprotease matrix |
| US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| NZ522990A (en) * | 2000-06-05 | 2003-08-29 | Dong A Pharm | Novel oxazolidinone derivatives and a process for the preparation thereof |
| JP2003321368A (ja) * | 2002-04-30 | 2003-11-11 | Azwell Inc | N,n’−ジ置換ウレアまたはチオウレア化合物含有医薬 |
| JP4480128B2 (ja) | 2002-11-20 | 2010-06-16 | 独立行政法人科学技術振興機構 | マトリックスメタロプロテアーゼ−9の産生を阻害するための薬剤 |
| EP1594852A1 (en) * | 2003-02-07 | 2005-11-16 | Ranbaxy Laboratories, Ltd. | Oxazolidinone derivatives as antimicrobials |
| MXPA05011654A (es) * | 2003-04-30 | 2005-12-15 | Morphochem Ag Komb Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| CN100544719C (zh) * | 2003-04-30 | 2009-09-30 | 莫弗凯姆联合化学股份公司 | 噁唑烷酮-喹啉杂化物抗生素用于制备治疗炭疽和其它感染的药物中的用途 |
| ES2310299T5 (es) | 2003-12-18 | 2014-02-10 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Antibióticos híbridos a base de oxazolidinona-quinolona |
| AU2006214378A1 (en) | 2005-02-16 | 2006-08-24 | Pharmacopeia, Inc. | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| JP5760248B2 (ja) * | 2006-09-12 | 2015-08-05 | 国立大学法人東京農工大学 | 腫瘍の骨転移抑制および/または予防剤 |
| JP2008276147A (ja) | 2007-04-02 | 2008-11-13 | Seiko Epson Corp | 現像装置、画像形成装置、及び、画像形成システム |
-
2009
- 2009-10-27 AU AU2009310952A patent/AU2009310952B2/en not_active Ceased
- 2009-10-27 JP JP2010535796A patent/JP5478499B2/ja not_active Expired - Fee Related
- 2009-10-27 DK DK09823571.6T patent/DK2364975T3/da active
- 2009-10-27 US US13/126,119 patent/US8354401B2/en not_active Expired - Fee Related
- 2009-10-27 CN CN200980148589.7A patent/CN102239152B/zh not_active Expired - Fee Related
- 2009-10-27 KR KR1020117012045A patent/KR101712679B1/ko not_active Expired - Fee Related
- 2009-10-27 WO PCT/JP2009/068386 patent/WO2010050461A1/ja not_active Ceased
- 2009-10-27 EP EP09823571.6A patent/EP2364975B1/en not_active Not-in-force
- 2009-10-27 ES ES09823571T patent/ES2427397T3/es active Active
- 2009-10-27 CA CA2741661A patent/CA2741661C/en not_active Expired - Fee Related
- 2009-10-27 PT PT98235716T patent/PT2364975E/pt unknown
- 2009-10-27 MX MX2011004372A patent/MX2011004372A/es active IP Right Grant
- 2009-10-27 PL PL09823571T patent/PL2364975T3/pl unknown
- 2009-10-27 TW TW98136276A patent/TWI471322B/zh not_active IP Right Cessation
- 2009-10-27 RU RU2011121362/04A patent/RU2487124C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| DK2364975T3 (da) | 2013-09-08 |
| CA2741661A1 (en) | 2010-05-06 |
| CA2741661C (en) | 2016-12-13 |
| MX2011004372A (es) | 2011-05-23 |
| JPWO2010050461A1 (ja) | 2012-03-29 |
| EP2364975B1 (en) | 2013-06-12 |
| RU2011121362A (ru) | 2012-12-10 |
| PT2364975E (pt) | 2013-09-09 |
| RU2487124C2 (ru) | 2013-07-10 |
| JP5478499B2 (ja) | 2014-04-23 |
| CN102239152B (zh) | 2014-10-29 |
| TWI471322B (zh) | 2015-02-01 |
| ES2427397T3 (es) | 2013-10-30 |
| US8354401B2 (en) | 2013-01-15 |
| CN102239152A (zh) | 2011-11-09 |
| KR101712679B1 (ko) | 2017-03-22 |
| EP2364975A1 (en) | 2011-09-14 |
| EP2364975A4 (en) | 2012-05-02 |
| TW201024290A (en) | 2010-07-01 |
| AU2009310952B2 (en) | 2015-04-30 |
| US20110263571A1 (en) | 2011-10-27 |
| WO2010050461A1 (ja) | 2010-05-06 |
| KR20110081312A (ko) | 2011-07-13 |
| AU2009310952A1 (en) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2150109A4 (en) | PHARMACEUTICAL USE OF SUBSTITUTED AMIDES | |
| IL209781A0 (en) | Novel immunoadjuvant flagellin-based compounds and use thereof | |
| IL212605A (en) | Pyrimidine-4-carboxamide cycles and their use as drugs | |
| GB0803018D0 (en) | Therapeutic compounds and their use | |
| PL2307391T3 (pl) | Tiadiazolilooksyfenyloamidyny i ich zastosowanie jako środki grzybobójcze | |
| IL211042A0 (en) | Imidazopyridin-2-one derivatives and uses thereof | |
| ZA201103635B (en) | Azaquinolinone derivatives and uses thereof | |
| IL209141A0 (en) | Novel substituted pyridin-2-ones and pyridazin-3-ones | |
| GB0804685D0 (en) | Therapeutic compounds and their use | |
| GB0817207D0 (en) | therapeutic apsac compounds and their use | |
| PL2307390T3 (pl) | Tiadiazolilooksyfenyloamidyny i ich zastosowanie jako środki grzybobójcze | |
| EP2336109A4 (en) | NOVEL PYRROLINONE DERIVATIVE AND DRUG COMPOSITION CONTAINING THE SAME | |
| HUE037850T2 (hu) | Új amidszármazék és alkalmazása gyógyszerként | |
| GB0817208D0 (en) | Therapeutic apsap compounds and their use | |
| GB0807609D0 (en) | Therapeutic compounds and their use | |
| IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
| IL215835A (en) | Carboxamide compounds and their use as a drug | |
| EP2268281A4 (en) | THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS | |
| EP2412701A4 (en) | NEW AMIDE DERIVATIVE AND SKIN LAUNDERING AGENT | |
| IL208771A0 (en) | Iminopyridine derivatives and use thereof | |
| PL2341047T3 (pl) | Pochodna cykloheksanowa i jej farmaceutyczne zastosowanie | |
| IL207423A0 (en) | Amide derivative and pharmaceutical composition containing the same | |
| GB0812913D0 (en) | Therapeutic compounds and their use | |
| EP2240021A4 (en) | NEW SEH-HEMMER AND ITS USE | |
| IL208824A0 (en) | Iminopyridine derivative and use thereof |